In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation of Wegovy.

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Bavarian Nordic has signed a manufacturing agreement with SII, expanding its strategic partnership through a contract for its ...

Curatis has signed an exclusive licensing and development agreement with Neupharma for corticorelin to treat peritumoral brain oedema in Japan.

In the warning letter, the FDA alleged that Novo inadequately responded to observations made after an inspection in 2025.

These UK-led efforts to support foreign infectious disease trials come after the US pulled foreign research aid to home in on domestic health ...

The investment in China follows similar outlays by the drugmaker in other regions as it prepares for high orforglipron demand.

Idorsia has signed an exclusive deal with Pharmalink Drug Store to distribute and commercialise its Quviviq therapy in various Gulf states.

The FDA has granted approval for the expanded use of GSK’s Wellcovorin to treat CFD in patients with a confirmed variant in the FOLR1 gene.

This new framework is the FDA's second scheme designed to streamline biosimilar development in the hopes of lowering drug prices.

Dubai is building life sciences clusters and research hubs, aiming to be a resilient healthcare and innovation center in a region facing ongoing conflict.

According to GlobalData, US vaccine manufacturers could be significantly hit by the reduced immunisation demand.